Merck & Co., Inc. is a global research-driven pharmaceutical company dedicated to putting patients first.

Investor Relations

Welcome to the Merck Investor Center
This site is designed to provide analysts and investors (institutional or retail) with quick and easy access to reliable, accurate and current information about Merck. Here you will find information on; historical company earnings, webcasts, presentations, transcripts, SEC filings, stock information and partnership information. For additional information, please visit About Merck.


News

01/05/2009 Merck to Hold Fourth-Quarter 2008 Sales and Earnings Conference Call on Feb. 3
12/18/2008 Merck & Co., Inc. Awards More Than $8 Million to Non-Profit Organizations in 2008 to Help Address HIV and AIDS Worldwide
12/12/2008 Merck Announces FDA Acceptance of Supplemental New Drug Application for ISENTRESS® (raltegravir) in Adult Patients Previously Untreated for HIV-1
Acrobat PDF file Full Prescribing Information Acrobat PDF file Patient Product Information
12/09/2008 Merck Outlines Long-Term Prospects and Progress on Strategic Plan at 2008 Annual Business Briefing
 

Contact Us | Site Map | Policy | Terms of Use | Copyright 1995-2009 Merck & Co., Inc.